-
Since Alzheimer’s dementia is one of the greatest problems in older age, it is clear that the early identification of symptoms and signs capable to predict the onset of the disease would be an important progress in prevention.
MedNews (Neurology) - Tue, 9 March 2010
http://mn.medsurfnews.com/
-
Comprehensive overview covers causes, treatment, coping skills for this communication disorder.
MayoClinic.com (Neurology) - Tue, 9 March 2010
http://www.mayoclinic.com
-
The National Institute for Health and Clinical Excellence (NICE) is currently developing guidance for the NHS on the use of non-invasive mechanical ventilation for people with motor neurone disease. The draft recommendations are now available on the NICE website for public consultation.
National Institute for Health and Clinical Excellence (Neurology) - Tue, 9 March 2010
http://www.nice.org.uk
-
Advances in molecular genetics and molecular biology have greatly expanded our knowledge of the disorders and the associated dysfunctional proteins that manifest as dementia, parkinsonism, and/or amyotrophic lateral sclerosis (ALS) and are encompassed by the term frontotemporal lobar degeneration (FTLD).
Archives of Neurology (Neurology) - Mon, 1 March 2010
http://archneur.ama-assn.org/
-
An assessment that reliably predicts the progression of Alzheimer's disease has been developed by researchers at Baylor College of Medicine.
Baylor College of Medicine (Neurology) - Mon, 1 March 2010
http://www.bcm.edu
-
Prophylaxis should be considered for patients whose migraines affect their quality of life despite appropriate symptomatic treatment, or who are at risk of headache through overuse of drugs, says a Canadian systematic review of studies investigating migraine prevention.
British Medical Journal (Neurology) - Mon, 22 February 2010
http://www.bmjjournals.com
-
Headache is increased among multiple sclerosis patients in most clinic-based studies and new research is suggesting a link.
Medscape (Neurology) - Mon, 22 February 2010
http://www.medscape.com
-
Why surgeon put faith in new treatment
A team in New York has reported the first results of a trial to test the theory that restricted blood flow in the brain may underlie some of the symptoms of multiple sclerosis.
Gianfranco Campalani knows a thing or two about the vascular system.
He's one of Northern Ireland's leading heart surgeons.
He was diagnosed with multiple sclerosis (MS) in 1986 - it left him with a series of problems in his lower body.
He finds it hard to walk more than fifty yards, or he did until he met an Italian compatriot and fellow vascular surgeon Professor Paolo Zamboni.
BBC News (Neurology) - Fri, 12 February 2010
http://news.bbc.co.uk
-
The patient is probably 30–40 years old, and four times more likely to be female than male. Symptoms might begin with Raynaud's syndrome, fatigue, or oesophageal reflux. Within months, these complaints might be followed by thickening of the skin of the arms, legs, and trunk, and within 3 years by congestive heart failure, interstitial lung disease, or renal crisis. The patient would have systemic sclerosis (scleroderma) and there would be no cure.
The Lancet (Neurology) - Fri, 12 February 2010
http://www.thelancet.com
-
Advances in molecular genetics and molecular biology have greatly expanded our knowledge of the disorders and the associated dysfunctional proteins that manifest as dementia, parkinsonism, and/or amyotrophic lateral sclerosis (ALS) and are encompassed by the term frontotemporal lobar degeneration (FTLD). The most relevant genes and their associated critical features are presented in the Table.
Archives of Neurology (Neurology) - Fri, 12 February 2010
http://archneur.ama-assn.org/